Skip to main content
The Bright Side
arrow_backHome
Nine out of ten: MRI reveals what this drug did to fatty liver
Health
Ynet HealthHE
October 1, 2026

Nine out of ten: MRI reveals what this drug did to fatty liver

Within almost a year and a half, the fat proportion in the livers of patients receiving the Wegovy weight‑loss injection dropped by two‑thirds, according to an analysis presented at the Diabetes Conference in Milan. Dr. Idith Dotan of Billerstein: "This is a significant shift in our perception of treating obesity and fatty liver." Eli Lilly, the competitor, presents an experimental combination of two drugs that reduced diabetic patients’ weight by almost a quarter in less than a year.

Read More
translateRead translated

Automatic translation by Google

Curated from Ynet Health. Classified as Health by AI, which sometimes makes mistakes.

Why are you reporting this article?

Why are you reporting this article?
0/500

More like this

More ›
Ynet Health10/12/2026

A claim denial does not necessarily stem from medical ineligibility

What should you do when a doctor recommends a critical and expensive medication that is not included in the public health basket, but the insurance company rejects the request, claiming the insurance policy lacks coverage? Before you exhaust savings or break down over a denial letter from the insurer, it is important to understand the financing mechanisms operating behind the scenes. A guide to exercising patient rights in Israel.